CLPT - CIK 0001285550
ClearPoint Neuro, Inc. trades as CLPT. In its fiscal 2025 annual report the company posted revenue of $36.97M, up 17.8% from the prior year and net income of -$25.54M. This page tracks ClearPoint Neuro, Inc. through 1,002 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years ClearPoint Neuro, Inc.'s revenue grew from $5.75M to $36.97M, a compound annual growth rate of 23.0%. Net profit margin expanded from -140.4% to -69.1% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider sale notice | 144 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
The largest companies sharing ClearPoint Neuro, Inc.'s SEC industry classification (surgical & medical instruments & apparatus).
ClearPoint Neuro, Inc. reported revenue of $36.97M for fiscal year 2025, an increase of 17.8% year over year.
In its latest fiscal year ClearPoint Neuro, Inc. reported a net loss of $25.54M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.